Ganoderma sichuanense (Ganodermataceae) is a medicinal mushroom originally described from China and previously confused with G. lucidum. It has been widely used as traditional medicine in Asia since it has potential nutritional and therapeutic values. We collected 8 specimens of Ganoderma species from Thailand and show that they represent the first record of G. sichuanenese for Thailand. In this paper, we describe our specimens of Ganoderma sichuanense based on fresh basidiomes, and provide line drawings and photographs. The data from macro-and microscopic features are consistent with the characteristics of the species. Analysis of ITS sequence data indicates that the Thai collections cluster in same species clade as the epitype of G. sichuanense.
Obba thailandica sp. nov. is described and illustrated from northern Thailand based on evidence from morphological characteristics and molecular data. The species produces annual, resupinate, white and waxy fresh basidiocarps, which become bone hard when dry, and has a very thin subiculum (< 0.1 mm), tomentose tube openings, weakly dextrinoid hyphae, variably shaped cystidioles, thin-walled and subglobose to globose basidiospores (4.8–5.8 × 4–4.9 μm) mostly with a large guttule and grows on charred pine wood. The new taxon is rather similar to O. rivulosa in both morphology and ecology, but O. rivulosa has fragile tubes when dry, a thick subiculum (up to 1 mm wide), smooth tube openings, indextrinoid hyphae, rhomboidal to irregular rosettes crystals on the tramal hyphae and long basidia (16–27 × 6–9.5 µm). In the phylogeny inferred from an ITS dataset, the new species forms a distinct lineage in the Obba clade and is closely related to O. rivulosa.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.